title: Tamoxifen-induced hirsutism.
abstract: Tamoxifen, a triphenylethylethylene, is an adjuvant therapy used for the treatment of oestrogen-receptor positive breast carcinoma due to its oestrogen receptor antagonist effect.1 We report here a case of rapid onset of hirsutism following administration of tamoxifen.
authors: Department of Dermatology, Salford Royal Hospital Trust, Manchester, UK. firas55@hotmail.com
authors: Firas
authors: F
authors: Al-Niaimi
authors: C
authors: C
authors: Lyon
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control; D017024:Chemotherapy, Adjuvant; D005260:Female; D006628:Hirsutism / Q000139:chemically induced*; D006801:Humans; D011960:Receptors, Estrogen / Q000187:drug effects*; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen; D013629:Tamoxifen